|
|
|
Insider
Information: |
Jones Evan/ Fa |
Relationship: |
Director |
City: |
Gaithersburg |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
112,146 |
|
Indirect Shares
|
448,791 |
|
|
Direct
Value |
$922,554 |
|
|
Indirect Value
|
$1,725,344 |
|
|
Total
Shares |
560,937 |
|
|
Total
Value |
$2,647,898 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-13.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Digene Corp |
DIGE |
Director |
2007-07-30 |
7,160 |
2007-07-26 |
0 |
Premium* |
|
CAS Medical Systems Inc |
CASM |
Director |
2013-06-24 |
44,768 |
2013-06-24 |
333,333 |
Premium* |
|
Fluidigm Corp |
FLDM |
Director |
|
0 |
2017-07-31 |
58,551 |
Premium* |
|
Veracyte, Inc. |
VCYT |
Director |
2024-03-01 |
37,601 |
2024-03-01 |
35,173 |
Premium* |
|
Foundation Medicine, Inc. |
FMI |
Director |
2018-07-31 |
0 |
2018-07-31 |
0 |
Premium* |
|
Opgen Inc |
OPGN |
Director |
2021-05-17 |
22,617 |
2020-10-27 |
21,734 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
268 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 11 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VCYT |
Veracyte, Inc. |
Director |
|
2015-11-25 |
4 |
S |
$7.23 |
$57,117 |
D/D |
(7,896) |
0 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2017-06-06 |
4 |
S |
$4.56 |
$43,344 |
I/I |
(9,500) |
54,951 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2017-06-07 |
4 |
S |
$4.41 |
$6,167 |
I/I |
(1,400) |
53,551 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2017-08-23 |
4 |
S |
$7.92 |
$158,400 |
I/I |
(20,000) |
322,153 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2017-08-24 |
4 |
S |
$7.83 |
$156,600 |
I/I |
(20,000) |
302,153 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2017-08-25 |
4 |
S |
$7.81 |
$156,200 |
I/I |
(20,000) |
282,153 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2017-08-28 |
4 |
S |
$7.84 |
$19,600 |
I/I |
(2,500) |
279,653 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
Director |
|
2017-12-05 |
4 |
S |
$60.94 |
$359,546 |
D/D |
(5,900) |
19,652 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
Director |
|
2017-12-06 |
4 |
S |
$57.88 |
$34,728 |
D/D |
(600) |
19,052 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
Director |
|
2017-12-13 |
4 |
S |
$62.05 |
$86,870 |
D/D |
(1,400) |
17,652 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2019-02-28 |
4 |
S |
$20.37 |
$1,527,803 |
I/I |
(75,000) |
204,653 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2019-08-09 |
4 |
S |
$26.38 |
$395,681 |
I/I |
(15,000) |
189,653 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2019-08-27 |
4 |
S |
$26.11 |
$88,760 |
I/I |
(3,400) |
186,253 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2019-08-28 |
4 |
S |
$26.10 |
$172,290 |
I/I |
(6,600) |
179,653 |
0 |
- |
|
OPGN |
Opgen Inc |
Chief Executive Officer |
|
2019-11-11 |
4 |
S |
$0.00 |
$0 |
I/I |
(6,000) |
26,211 |
0 |
- |
|
OPGN |
Opgen Inc |
Director |
|
2020-09-04 |
4 |
S |
$2.19 |
$7,910 |
I/I |
(3,612) |
23,482 |
0 |
- |
|
OPGN |
Opgen Inc |
Director |
|
2020-10-27 |
4 |
S |
$2.35 |
$4,108 |
I/I |
(1,748) |
21,734 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2024-03-01 |
4 |
S |
$24.36 |
$243,599 |
D/D |
(10,000) |
37,601 |
0 |
% |
|
268 Records found
|
|
Page 11 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|